![Monique Tello is starting a new position as Medical Director of Clinical Development at Immunocore](https://oncodaily.com/pub/uploads/2024/05/845a6965816f4135bba1de7876b595c6.png)
Photo of Monique Tello and Immunocore
May 10, 2024, 01:24
Monique Tello is starting a new position as Medical Director of Clinical Development at Immunocore
Monique Tello, Medical Director, Clinical Development at Immunocore, shared on LinkedIn:
“I’m happy to share that I’m starting a new position as Medical Director, Clinical Development at Immunocore, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases. Immunocore discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy, and I’m thrilled to contribute to the development of more promising therapies across a broad range of indications, including multiple cancers, HIV and HBV.”
Source: Monique Tello/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023